Company Valuation: VVT Med Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2025
Market Cap 1 14.68
Change -
Enterprise Value (EV) 1 15.6
Change -
P/E -2.71x
PBR -8.07x
PEG 0x
Capitalization / Revenue 165x
EV / Revenue 175x
EV / EBITDA -6.04x
EV / EBIT -6.03x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 -0.081
Distribution rate -
Net sales 1 0.089
EBITDA 1 -2.582
EBIT 1 -2.585
Net income 1 -3.976
Net Debt 1 0.911
Reference price 2 0.2194
Nbr of stocks (in thousands) 66,933
Announcement Date 6/30/26
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 10.46M
29.21x4.03x15.58x2.49% 177B
19.84x3.61x12.91x3% 120B
17.86x0.21x13.03x0.73% 61.69B
35.25x3.41x11.68x2.15% 50.64B
27.51x6.75x17.39x1.45% 48.16B
33.94x5.96x18.72x-.--% 32.62B
42.07x1.24x11.48x0.22% 28.17B
41.42x7.26x26.04x0.25% 25.69B
16.86x2.69x9.53x1.64% 21.33B
Average 29.33x 3.91x 15.15x 1.33% 56.48B
Weighted average by Cap. 27.38x 3.77x 14.76x 1.9%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. VVTM Stock
  4. Valuation VVT Med Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!